Literature DB >> 15197284

Anti-aging medicine: can consumers be better protected?

Maxwell J Mehlman1, Robert H Binstock, Eric T Juengst, Roselle S Ponsaran, Peter J Whitehouse.   

Abstract

The use of interventions claiming to prevent, retard, or reverse aging is proliferating. Some of these interventions can seriously harm older persons and aging baby boomers who consume them. Others that are merely ineffective may divert patients from participating in beneficial regimens and also cause them economic harm. "Free market regulation" does not seem to weed out risky, ineffective, and fraudulent anti-aging treatments and products. Public health messages, apparently, are having little effect. What more can be done to achieve better protection for older consumers? An analysis of the potential for federal and state action reveals many barriers to effective governmental regulation of anti-aging interventions. In view of dim prospects for stronger public regulation, physicians and other professionals--especially geriatricians and gerontologists--will need to be more aggressive in protecting older consumers. In particular, The Gerontological Society of America and the American Geriatrics Society should undertake a sustained program of specific educational efforts, directed at health professionals and the general public, in which they sort out as best they can the helpful, the harmful, the fraudulent, and the harmless anti-aging practices and products. Copyright 2004 The Gerontological Society of America

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197284     DOI: 10.1093/geront/44.3.304

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  6 in total

Review 1.  Successful aging: Advancing the science of physical independence in older adults.

Authors:  Stephen D Anton; Adam J Woods; Tetso Ashizawa; Diana Barb; Thomas W Buford; Christy S Carter; David J Clark; Ronald A Cohen; Duane B Corbett; Yenisel Cruz-Almeida; Vonetta Dotson; Natalie Ebner; Philip A Efron; Roger B Fillingim; Thomas C Foster; David M Gundermann; Anna-Maria Joseph; Christy Karabetian; Christiaan Leeuwenburgh; Todd M Manini; Michael Marsiske; Robert T Mankowski; Heather L Mutchie; Michael G Perri; Sanjay Ranka; Parisa Rashidi; Bhanuprasad Sandesara; Philip J Scarpace; Kimberly T Sibille; Laurence M Solberg; Shinichi Someya; Connie Uphold; Stephanie Wohlgemuth; Samuel Shangwu Wu; Marco Pahor
Journal:  Ageing Res Rev       Date:  2015-10-14       Impact factor: 10.895

2.  Are "anti-aging medicine" and "successful aging" two sides of the same coin? Views of anti-aging practitioners.

Authors:  Michael A Flatt; Richard A Settersten; Roselle Ponsaran; Jennifer R Fishman
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2013-09-10       Impact factor: 4.077

Review 3.  Tragedy and delight: the ethics of decelerated ageing.

Authors:  David Gems
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-01-12       Impact factor: 6.237

4.  Regulatory aspects of mild cognitive impairment: toward a harmonized perspective.

Authors:  Peter J Whitehouse
Journal:  Dialogues Clin Neurosci       Date:  2004-12       Impact factor: 5.986

5.  Ethical issues in early diagnosis and prevention of Alzheimer disease.

Authors:  Peter J Whitehouse
Journal:  Dialogues Clin Neurosci       Date:  2019-03       Impact factor: 5.986

6.  Evaluating the Investment Projects of Spinal Medical Device Firms Using the Real Option and DANP-mV Based MCDM Methods.

Authors:  Chi-Yo Huang; Hong-Ling Hsieh; Hueiling Chen
Journal:  Int J Environ Res Public Health       Date:  2020-05-11       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.